work, Ipamorelin released GH with potency comparable to the older peptide GHRP-6 but, unlike GHRP-6 and GHRP-2, did not meaningfully elevate adrenocorticotropic hormone (ACTH), cortisol, or prolactin even at doses well above the GH-releasing threshold
Conversely, if you are at steady state and experiencing no therapeutic benefit (no appetite change, no metabolic effects), the plotter confirms that the dose has had its full chance
If youre considering Sermorelin therapy , our experienced medical team provides personalized telehealth consultations, individualized treatment plans, and ongoing follow-up for eligible adults
Warburg O, Wind F, Negelein E